Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Operating Leases (2023 - 2025)

Rallybio's Operating Leases history spans 3 years, with the latest figure at $108000.0 for Q3 2025.

  • For Q3 2025, Operating Leases changed N/A year-over-year to $108000.0; the TTM value through Sep 2025 reached $108000.0, changed N/A, while the annual FY2023 figure was $392000.0, N/A changed from the prior year.
  • Operating Leases for Q3 2025 was $108000.0 at Rallybio, up from $58000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $392000.0 in Q4 2023 and bottomed at $58000.0 in Q2 2024.
  • The 3-year median for Operating Leases is $211000.0 (2023), against an average of $210285.7.
  • The largest YoY upside for Operating Leases was 63.86% in 2024 against a maximum downside of 78.2% in 2024.
  • A 3-year view of Operating Leases shows it stood at $392000.0 in 2023, then crashed by 85.2% to $58000.0 in 2024, then soared by 86.21% to $108000.0 in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Operating Leases are $108000.0 (Q3 2025), $58000.0 (Q2 2024), and $116000.0 (Q1 2024).